The CD3 versus CD7 Plot in Multicolor Flow Cytometry Reflects Progression of Disease Stage in Patients Infected with HTLV-I

• Seiichiro Kobayashi,

  Affiliation Division of Molecular Therapy, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

  ⨯
• Yamin Tian,

  Affiliations Division of Molecular Therapy, Institute of Medical Science, The University of Tokyo, Tokyo, Japan, Department of Molecular Genetics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan

  ⨯
• Nobuhiro Ohno,

  Affiliation Department of Hematology/Oncology, Research Hospital, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

  ⨯
• Koichiro Yuji,

  Affiliation Department of Hematology/Oncology, Research Hospital, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

  ⨯
• Tomohiro Ishigaki,

  Affiliation Laboratory of Diagnostic Medicine, Division of Stem Cell Therapy, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

  ⨯
• Masamichi Isobe,

  Affiliation Department of Hematology/Oncology, Research Hospital, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

  ⨯
• Mayuko Tsuda,

  Affiliation Department of Hematology/Oncology, Research Hospital, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

  ⨯
• Naoki Oyaizu,

  Affiliation Clinical Laboratory, Research Hospital, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

  ⨯
• Eri Watanabe,

  Affiliation Laboratory of Diagnostic Medicine, Division of Stem Cell Therapy, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

  ⨯
• Nobukazu Watanabe,

  Affiliation Laboratory of Diagnostic Medicine, Division of Stem Cell Therapy, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

  ⨯
• Kenzaburo Tani,

  Affiliation Department of Molecular Genetics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan

  ⨯
• Arinobu Tojo,

  Affiliations Division of Molecular Therapy, Institute of Medical Science, The University of Tokyo, Tokyo, Japan, Department of Hematology/Oncology, Research Hospital, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

  ⨯
• Kaoru Uchimaru

  * E-mail: uchimaru@ims.u-tokyo.ac.jp

  Affiliation Department of Hematology/Oncology, Research Hospital, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

  ⨯